TheFiscalFinder
● Single award · contract

Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG…

A single federal award, with both ends of the trail linked.
$227.7M
total award value
2025
action date
24 mo
period
75A50325F80013
PIID
Agency ›
Department of Health and Human Services
✓ from source
awarded→$227.7M
Recipient ›
Alvogen, Inc.
✓ from source
performed in→
State ›
New Jersey
✓ from source

Description

Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG Capsules (Ndc: 47781-468-13); 10 Ct. Blisters Packs.

Awarding agencyDepartment of Health and Human Services →
RecipientAlvogen, Inc. →
Place of performanceNew Jersey →
CategoryNAICS 325412PSC 6505
Competed?Not recorded✓ from source
Total (exact)$227,679,090

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
Medicaid Entitlement for 7 - Fy 2022 Quarter 4 - T19
awarded 2022$71.7B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.